FASN and Familial prostate cancer: This study demonstrated that uptake of radiolabeled acetate is able to predict outcome of FASN-targeted therapy and that FASN inhibition not only suppressed cell proliferation but also prevented pseudopodia formation and suppressed cell adhesion, migration, and invasion, with human prostate cancer cell lines.